Attex atomoxetine brand?

What company owns the brand Attex?

Attex is a brand name for the medication atomoxetine, which is used to treat attention deficit hyperactivity disorder (ADHD). The brand is owned by various companies in different regions due to licensing agreements and patent rights.

Why are there different owners for Attex?

The patent for atomoxetine expired in various countries at different times. As a result, different generic and branded versions of the medication became available.

When does the patent for Attex expire?

According to DrugPatentWatch.com [1], the patent for atomoxetine expired in the United States in 2017. However, the patent may still be valid in other countries, and it's essential to check the specific patent status for each region.

Who makes the generic version of atomoxetine?

Several pharmaceutical companies, such as Mylan and Sandoz, produce generic versions of atomoxetine. These generics may offer lower prices than branded versions like Attex.

What's the difference between branded and generic atomoxetine?

Branded and generic versions of atomoxetine have the same active ingredient, but they may differ in terms of formulation, packaging, and pricing. Generics can offer significant cost savings for patients, but they may not be as widely available as branded versions.

How does the availability of generic atomoxetine affect patients?

The availability of generic atomoxetine can make the medication more affordable for patients, especially those without health insurance or with limited coverage. However, patients should always consult with their healthcare provider before switching between branded and generic versions to ensure the best treatment outcome.

Sources:

[1] DrugPatentWatch.com: Atomoxetine Patent Expiration https://www.drugpatentwatch.com/pharma/patents/100010